JW Holdings Corporation (KRX:096760)
4,105.00
-125.00 (-2.96%)
At close: Oct 8, 2026
JW Holdings Revenue
JW Holdings had revenue of 266.47B KRW in the quarter ending June 30, 2026, with 16.68% growth. This brings the company's revenue in the last twelve months to 1.01T, up 10.18% year-over-year. In the year 2025, JW Holdings had annual revenue of 969.57B with 9.22% growth. That makes JW Holdings the 8,970th largest company in the world by revenue and 409th in South Korea.
Revenue (ttm)
1.01T
Revenue Growth
+10.18%
P/S Ratio
0.28
Revenue / Employee
8.87B
Employees
114
Market Cap
284.03B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 969.57B | 81.86B | 9.22% |
| Dec 31, 2024 | 887.71B | -40.36B | -4.35% |
| Dec 31, 2023 | 928.07B | 63.54B | 7.35% |
| Dec 31, 2022 | 864.54B | 75.60B | 9.58% |
| Dec 31, 2021 | 788.94B | 7.42B | 0.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Dong-A ST | 860.94B |
| Suheung | 765.90B |
| Huons | 607.75B |
| Samjin Pharmaceuticals | 274.03B |
| Bukwang Pharmaceutical | 215.09B |
| Korea United Pharm | 161.44B |
| Humedix | 110.99B |
| Hyundai Pharmaceutical | 108.14B |